High-Risk Drug Monitoring Service

High-Risk Drug Monitoring Service .

Systematic monitoring of high-risk medicines across the practice list — DMARDs, lithium, amiodarone, anticoagulants, valproate — with pharmacist-led recall and prescribing safety reporting. Delivered nationally from the BCS Halifax (Yorkshire) and Chiswick (London) hubs — the only UK dual-hub clinical pharmacy provider.

What you get

What this looks like in practice.

  • Quarterly DMARD bloods recall and recording
  • Anticoagulant INR / DOAC reviews
  • Lithium and amiodarone monitoring cycles
  • Valproate Pregnancy Prevention Programme oversight
  • Safety alert action and audit evidence

Also known as.

This service is often referred to as High Risk Medicines monitoring, DMARD monitoring, Anticoagulant monitoring, Lithium monitoring. BCS delivers it as one canonical, ARRS-compliant managed service.

Why BCS

Built for primary care, at scale.

2 hubs
Halifax + Chiswick — unique to BCS
4–6 wks
Typical mobilisation
100%
Supervision evidenced
Monthly
QA-checked reporting

Frequently asked questions — High-Risk Drug Monitoring Service.

Does BCS handle MHRA safety alert response?+

Yes — every active MHRA alert is mapped to a BCS pharmacist workflow with action evidence per practice.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call